432 Results
APA Ethics Committee Issues Opinion on the Spread of Disinformation
"When speaking publicly about a pandemic, therefore, it is particularly incumbent upon psychiatrists to honestly and responsibly share factual information,” states a new opinion from the American Psychiatric Association’s Ethics Committee. “Disseminating falsehoods about a pandemic disease such as COVID-19, including misleading information about scientifically supported public health protocols or vaccines, is unethical.”
Racial Disparities in Childhood Adversity Linked to Brain Structural Differences in U.S. Children
Black children in the United States are more likely to experience childhood adversity than White children, and these disparities are reflected in differential changes to regions of the brain linked to psychiatric disease like posttraumatic stress disorder (PTSD), according to new research led by McLean Hospital, a member of Mass General Brigham.
APA SAMHSA Minority Fellowship Program Highlight: Dr. Atasha Jordan
Meet Dr. Atasha Jordan, an APA SAMHSA Minority Fellow. The SAMHSA Minority Fellowship Program (MFP) aims to reduce health disparities and improve behavioral health care outcomes for racial and ethnic populations.
Media Advisory: Top Experts on Addiction, Mental Illness Available Ahead of Recovery Month
September is Recovery Month, a time to emphasize that recovery from addiction and other mental illness is possible. The story of recovery is important to share as the United States remains in an opioid overdose epidemic.
Congress, Federal Agencies Extend Pandemic Telehealth Flexibilities
Some key telehealth services will be extended until March 31, 2025, as part of the American Relief Act, signed by President Biden on December 21.
Joint Statement on Federal Concerns About Psychotropic Medication Safety
The safety and efficacy of traditional antidepressants, antipsychotics, and mood stabilizers (such as lithium and some anticonvulsants) and stimulant medications have been established through decades of rigorous research, randomized clinical trials, peer-reviewed studies, meta-analyses, national registry studies of thousands of people, post-marketing pharmacovigilance monitoring, and FDA oversight.
Personal Perspectives on Family Engagement and Support
Ken Duckworth, M.D., chief medical officer, National Alliance on Mental Illness (NAMI) leads a deep discussion with individuals who reflect on their years of lived experience with serious mental illness (SMI) and the critical role family members played in their journeys.
Online Support for People with Mental Health Conditions
While these unprecedented times are stressful for everyone, people with mental health conditions may face particular challenges. Many organizations offer ways to connect and find support online or by phone for general mental health and for specific conditions.
Expanding Mental Health Uses for Virtual Reality
Virtual reality technology is increasingly being used to support mental health and treat a variety of mental health disorders, especially as the technology becomes more familiar and more affordable. Virtual reality (VR) offers several advantages, including convenience and the ability to adapt and individualize it. Among the conditions being effectively treated with VR are PTSD, anxiety and phobias.
Cannabis: Understanding the Risks
At a recent session at the APA Annual Meeting, a panel of psychiatrists addressed many of the common misconceptions around cannabis. With more states legalizing cannabis and changing public perceptions, there is confusion around its safety and uses.
Explore Sessions from SAMHSA and SMI Adviser
These sessions, presented by the SAMHSA and SMI Adviser, will explore strategies and tools for treating patients with serious mental illness
Explore Sessions from SAMHSA and SMI Adviser
These sessions, presented by the SAMHSA and SMI Adviser, will explore strategies and tools for treating patients with serious mental illness.